| Tejinder Khera, | |
|
3101 Green Valley Rd, Cameron Park, CA 95682-7647 | |
| (530) 672-8908 | |
| Not Available |
| Full Name | Tejinder Khera |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3101 Green Valley Rd, Cameron Park, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265722870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 64328 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tejinder Khera, 508 San Marco Pl, El Dorado Hills, CA 95762-5228 Ph: (530) 933-1403 | Tejinder Khera, 3101 Green Valley Rd, Cameron Park, CA 95682-7647 Ph: (530) 672-8908 |
News Archive
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has closed on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited, a top 20 pharmaceutical company, for the development of its novel anti-cancer compound, RX-3117. RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that has an anti-metabolite mechanism of action, and has therapeutic potential in a broad range of cancers including colon, lung and pancreatic cancer.
Oropharyngeal cancer patients who were found to have detectable traces of human papillomavirus type 16 (HPV16) in their saliva following cancer treatment are at an increased risk for recurrence, a study led by researchers at the Johns Hopkins Bloomberg School of Public Health has found.
The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson's disease who are currently taking levodopa/carbidopa and experiencing "off" episodes.
Australia is a leader in digital mental health technologies; this week experts will gather at the University of Sydney to forge a path for unbiased, safe and quality mental health apps.
Developing and testing a new anti-cancer drug can cost billions of dollars and take many years of research.
› Verified 3 days ago
Navjot Kaur Bisla, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3380 Coach Ln, Cameron Park, CA 95682 Phone: 530-676-6938 Fax: 530-676-6942 | |
Michel Gellad, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3020 Green Valley Rd, Cameron Park, CA 95682 Phone: 530-676-6352 | |
Erin Mullins, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3380 Coach Ln, Cameron Park, CA 95682 Phone: 530-676-6938 Fax: 530-676-6942 | |
Linda Nghiem, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3020 Green Valley Rd, Cameron Park, CA 95682 Phone: 530-676-6352 | |
Samantha Ericka Carmona Gonzalo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4014 Plaza Goldorado Cir, Cameron Park, CA 95682 Phone: 530-676-2095 | |
Ying Jin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3020 Green Valley Rd, Cameron Park, CA 95682 Phone: 530-676-6352 | |
Dr. Martin Joseph Cordova, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Palmer Dr, Cameron Park, CA 95682 Phone: 530-676-4833 |